The U.S. Food and Drug Administration has approved the antipsychotic drug Abilify (aripiprazole) for adolescents aged 13 to 17 diagnosed with schizophrenia. References and Resources U.S. Food and…
This update highlights changes to the prescribing information for Avandia including a new boxed warning about the potential increased risk of myocardial ischemia. References and Resources FDA adds…
Avastin shows promise in a phase II study in glioblastoma multiforme. References and Resources Avastin Clinical Trial Information Click Here to view information. Vredenburgh J, Desjardins A, Herndon…
John A. Daller, MD, PhD, FACS, Associate Professor, Director, Abdominal Organ Transplantation, Temple University School of Medicine, discusses renal transplantation. References and Resources Renal Failure, Chronic and Dialysis…
The FDA has approved Zyrtec-D for nonprescription use in adults and children 12 years of age and older. References and Resources FDA Approves Nonprescription Zyrtec-D for Allergies Click…
Gary S. Cohen, MD, Chief, Vascular Interventional Radiology, Vice Chairman of Clinical Services, Professor of Radiology, Temple University School of Medicine, discusses uterine artery embolization. References and Resources…
Gary S. Cohen, MD, Chief, Vascular Interventional Radiology, Vice Chairman of Clinical Services, Professor of Radiology, Temple University School of Medicine, discusses a possible treatment for early stage…
Gerard J. Criner, MD, Director/Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses research using combination therapy for treatment of chronic…
Gerard J. Criner, MD, Director/Professor of Medicine, Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, discusses a recent clinical trial with combination drug therapies…
James P. Moises, MD, Assistant Clinical Professor of Surgery, Department of Emergency Medicine, Clerkship Director of Emergency Medicine, Tulane University Hospital and Clinic, discusses treatment options for agitated…
